2-Bromo-3-nitro-4-picoline | CAS:23056-45-3

We serve 2-Bromo-3-nitro-4-picoline CAS:23056-45-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-3-nitro-4-picoline

Chemical Name:2-Bromo-3-nitro-4-picoline
CAS.NO:23056-45-3
Synonyms:2-Bromo-3-nitro-4-picoline
2-bromo-4-methyl-3-nitropyridine
2-bromo-3-nitro-4-methyl pyridine
3-Nitro-2-bromo-4-methylpyridine
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 263.3±35.0 °C at 760 mmHg
Molecular Formula C6H5BrN2O2
Molecular Weight 217.020
Flash Point 113.0±25.9 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.600
 
Specification:
Appearance:Brown crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Bromo-3-nitro-4-picoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Nitro-2-bromo-4-methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Nitro-2-bromo-4-methylpyridine Use and application,2-bromo-4-methyl-3-nitropyridine technical grade,usp/ep/jp grade.


Related News: The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.boc-l-tyr-ol manufacturer Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.(S)-3-Acetylthio-2-methylpropionyl-L-proline supplier The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.1-Acetyl-2-imidazolidinone vendor As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.The mode of cooperation between domestic API companies and large international companies can lower the export threshold.